Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- New York, New York
- Most recent report
- 8-K, filed Sep 3, 2026
- Incorporated
- Delaware
- Filings on record
- 131 filings
- On EDGAR
- CIK 1691082
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 4
News 8 of 15
Prospectuses and Registrations 8 of 14
- 424B3 Prospectus supplement for an offering Sep 3, 2026
- 424B3 Prospectus supplement for an offering Aug 11, 2026
- 424B3 Prospectus supplement for an offering Jul 29, 2026
- 424B3 Prospectus supplement for an offering Jul 22, 2026
- 424B3 Prospectus supplement for an offering Jun 10, 2026
- 424B3 Prospectus supplement for an offering Jun 9, 2026
- 424B3 Prospectus supplement for an offering May 12, 2026
- 424B3 Prospectus supplement for an offering Apr 14, 2026
Proxies 2
Ownership 8 of 65
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- 4 Insider reported a trade Aug 3, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 29, 2026
- SCHEDULE 13G Large holder reported a passive stake Jul 16, 2026
- 144 Notice of a proposed sale of restricted stock Jun 9, 2026
- 4 Insider reported a trade Jun 5, 2026
- 4 Insider reported a trade Jun 5, 2026
- 4 Insider reported a trade Jun 5, 2026
Other 8 of 31
- ARS Annual report sent to shareholders Apr 23, 2026
- EFFECT Notice that a registration became effective Apr 14, 2026
- CORRESP Reply to SEC staff Apr 10, 2026
- UPLOAD Comment letter from SEC staff Apr 10, 2026
- EFFECT Notice that a registration became effective Sep 10, 2025
- S-1MEF Sep 10, 2025
- CERT Exchange certified a listing Sep 10, 2025
- CORRESP Reply to SEC staff Sep 9, 2025
Everything here comes from Lb Pharmaceuticals Inc's own filings on SEC EDGAR. The filing list is rechecked every hour.